Persistent Coronavirus Disease 2019 (COVID-19) in an Immunocompromised Host Treated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific Monoclonal Antibodies.

ABSTRACT:

SUBMITTER: Bailly B 

PROVIDER: S-EPMC8522390 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature